• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Boston Scientific (NY: BSX )

    83.62 -0.40 (-0.48%)
    Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Boston Scientific

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Why Medical Devices Giant Boston Scientific Shares Are Rising Today
    Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024. 
    Via Benzinga
    Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance
    The company expects sales to grow 7% to 9% organically, above expectations. 
    Via Investor's Business Daily
    Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts
    Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts. 
    Via Investor's Business Daily
    Topics Earnings
    Exposures Financial
    Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
    The record run of the market faces risk as the big tech earnings season got off to a negative start, casting cloud on profit outlook. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Preview: Boston Scientific's Earnings
    Via Benzinga
    Looking Into Boston Scientific's Recent Short Interest
    Via Benzinga
    Demystifying Boston Scientific: Insights From 10 Analyst Reviews
    Via Benzinga
    Earnings Scheduled For January 31, 2024
    Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
    Via Benzinga
    Why Axonics Stock Soared Today
    The medical device maker agreed to be acquired by Boston Scientific. 
    Via The Motley Fool
    Boston Scientific Corporation Should Continue Uptrend & Remain Supported
    Boston Scientific Corporation develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular segments. 
    Via Talk Markets
    Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
    An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Health Care Company Boston Scientific Announces Acquisition of Axonics
    Via Benzinga
    Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
    Via Benzinga
    Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
    Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
    Via Benzinga
    Chart Of The Day: Boston Scientific - Revenue Growth Potential
    Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. 
    Via Talk Markets
    Palo Alto Networks, Nvidia, And 2 Other Stocks Insiders Are Selling
    The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Boston Scientific Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
    Via Benzinga
    7 Healthcare Stocks Taking Medicine to the Next Level
    With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider. 
    Via InvestorPlace
    Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
    The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. 
    Via Investor's Business Daily
    Topics ETFs
    5 A-Rated Stocks to Buy ASAP in 2024
    2024 is ushering in a new era for investors, and these top-notch, A-rated stocks to buy are likely to be market winners. Here's why. 
    Via InvestorPlace
    10 Top Stocks With a Strong Buy Rating Right Now
    Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch. 
    Via InvestorPlace
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Why Is Axonics (AXNX) Stock Up 20% Today?
    Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific. 
    Via InvestorPlace
    Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?
    Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7 
    Via Benzinga
    J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
    The year's biggest medical conference kicked off with a melee of buyout news. 
    Via Investor's Business Daily
    Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
    From Axonics, Inc.
    Via Business Wire
    Stock Picks 2024: 7 Trailblazers Using AI to Revolutionize Their Industries
    Although AI-related stock picks for 2024 may be centered on tech firms, the innovation itself achieves broad relevance. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Why Medical Devices Behemoth Boston Scientific Shares Are Rising Friday
    Boston Scientific Corporation (NYSE: BSX) said it expects FARAPULSE Pulsed Field Ablation (PFA) System to get  
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.